The automated clinical trial eligibility screener analyzes EHR data such as patient demographics and clinical assessments as well as information from clinical notes, including the patients’ clinical conditions, symptoms and treatments. The data is then matched with eligibility requirements to evaluate whether a patient is suitable for a specific clinical trial.
To test ACTES, researchers integrated it into the clinical research coordinators’ workflow in the pediatric emergency department at Cincinnati Children’s Hospital Medical Center. During the one-year trial period, the system screened EHR data for the current ED patients and recommended potential candidates for clinical trials.
Results of the trial showed ACTES reduced patient screening time by 34 percent compared to manually screening EHRs. The system also boosted patient enrollment by 11.1 percent and improved the number of patients screened by 14.7 percent.
While ACTES was able to help streamline patient screenings, the research team concluded that the system needs to be tested in other studies because it was only tested in a single clinical department for this study.
More articles on artificial intelligence:
Children’s National Health to apply AI to study ICU transitions
Microsoft invests $1B for development of superhuman AI
10 most common AI uses in healthcare
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.